Clinical Trials Browser

Phase 1/2 × Cryosurgery × Breast × Clear all

Triple Negative Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

100 enrolled

Breast

Breast Neoplasms

NCT01065441 2020-01-22

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Phase 1/2 Completed

9 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT02018419 2020-01-22

MBC

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT02844335 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

Phase 1/2 Completed

60 enrolled

Breast

Breast Neoplasms

Clinical Trials

LOGIC

Safety and Efficiency of γδ T Cell Against Breast Cancer

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

MBC

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer